Basic information Safety Supplier Related

SU 5205

Basic information Safety Supplier Related

SU 5205 Basic information

Product Name:
SU 5205
Synonyms:
  • SU 5205
  • 2H-Indol-2-one, 3-[(4-fluorophenyl)methylene]-1,3-dihydro-
  • SU 5205; SU-5205; SU5205
  • mitogenesis,Inhibitor,VEGFR2,Vascular endothelial growth factor receptor,FLK-1,SU-5205,endothelial,VEGFR,SU5205,inhibit
  • SU5205, 10 mM in DMSO
  • (z)-3-(4-fluorobenzylidene)indolin-2-one
CAS:
3476-86-6
MF:
C15H10FNO
MW:
239.24
Mol File:
3476-86-6.mol
More
Less

SU 5205 Chemical Properties

Melting point:
194-196 °C
Boiling point:
435.3±45.0 °C(Predicted)
Density 
1.306±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
solubility 
DMF: 50 mg/ml; DMSO: 50 mg/ml; DMSO:PBS(pH 7.2) (1:3): 0.25 mg/ml; Ethanol: 5 mg/ml
form 
A crystalline solid
pka
12.69±0.20(Predicted)
color 
White to yellow
More
Less

SU 5205 Usage And Synthesis

Uses

SU5205 is an inhibitor of VEGFR2 (FLK-1), with an IC50 of 9.6 μM[1].

Biological Activity

SU5205 is an inhibitor of VEGF receptor 2 (VEGFR2/FLK-1) with IC50 of 9.6 μM.

Synthesis

59-48-3

459-57-4

3476-86-6

GENERAL STEPS: 2-Indolone (1 eq.) and p-fluorobenzaldehyde (1 eq.) were added to ethanol (EtOH, 3 mL/0.2 mmol) and the mixture was stirred until completely dissolved. Subsequently piperidine (0.1 eq.) was added and the reaction mixture was heated to 90 °C and kept reacting for 3-7 hours. After completion of the reaction, it was cooled to room temperature. The resulting precipitate was collected by filtration, washed with cold ethanol and dried to give 3-(4-fluorophenylmethylene)indolin-2-one crude. If further purity is required, the product can be purified by ethanol recrystallization.

in vitro

SU5205 inhibits ligand-induced endothelial mitogenesis for VEGF with an IC 50 of 5.1 μM.

target

TargetValue
VEGFR2
(Cell-free assay)
9.6 μM

IC 50

Flk-1: 9.6 μM (IC50)

References

[1] Huh S, et al. Melanogenesis inhibitory effect of fatty acid alkyl esters isolated from Oxalis triangularis. Biol Pharm Bull. 2010;33(7):1242-5. DOI:10.1248/bpb.33.1242
[2] Torsten K, et, al. Synthesis and radiopharmacological investigation of 3-[4'-[(18)F]fluorobenzylidene]indolin-2-one as possible tyrosine kinase inhibitor. Bioorg Med Chem. 2009 Nov 15; 17(22): 7732-42.

SU 5205Supplier

Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66113011 17798518460
Email
cfzhang@aikonchem.com
Shanghai JiYi Biotechnology Co. Ltd.
Tel
13621943973
Email
sales@shjiyipharmatech.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Tianjin Kailiqi Biotechnology Co., Ltd.
Tel
15076683720
Email
klq@cw-bio.com
Shanghai Chaolan Chemical Technology Center
Tel
021-QQ:65489617 15618227136
Email
Sales@ATKchemical.com